Resting-State EEG Reveals Spectral Power and Connectivity Changes in MSA

Neurodegenerative disorders can quietly reorganize how the brain communicates, long before symptoms fully declare themselves. In a new study, researchers report that multiple system atrophy (MSA)—a progressive condition affecting movement and autonomic function—shows distinct patterns in resting-state brain activity when measured with electroencephalography (EEG). The findings focus on two complementary signals: spectral power and functional connectivity, offering a more integrated view of brain dysfunction than either metric alone.

Using resting-state EEG, the team quantified how power is distributed across frequency bands and how synchrony links distant brain regions. Spectral power changes can reflect shifts in local neural dynamics, while functional connectivity captures the statistical coupling between cortical areas. Together, these measures provide a systems-level fingerprint of disease-related brain alterations.

Across participants with MSA, the authors observed abnormal spectral signatures, particularly in frequency ranges commonly associated with attention, sensorimotor processing, and large-scale network regulation. While the study emphasizes group-level differences, the approach also supports individual variability analysis by treating EEG rhythms as measurable phenotypes rather than qualitative impressions.

Functional connectivity analysis further revealed reorganization of network coupling in MSA. By examining how oscillatory activity becomes coordinated—or decoupled—between brain regions, the researchers highlight disruptions consistent with impaired communication across functional networks. Such connectivity shifts can indicate altered information transfer, potentially contributing to the clinical deterioration seen in MSA.

The study leverages the advantage of EEG: high temporal resolution that can detect changes in ongoing neural rhythms. Unlike methods that require task performance, resting-state recording enables comparisons under controlled, low-cognitive-demand conditions. This strengthens the translational promise of EEG biomarkers for screening and longitudinal monitoring.

Importantly, the work frames spectral and connectivity results as related dimensions of the same underlying neural disturbance. Altered power can modulate synchronization, while connectivity changes can reshape how rhythmic activity propagates across networks. The study’s combined analysis therefore improves interpretability of what “goes wrong” in MSA physiology.

By grounding their conclusions in measurable EEG-derived features, the authors suggest pathways for future biomarker development. With refinement—such as larger cohorts, standardized preprocessing, and validation across sites—resting-state EEG may support earlier detection and better stratification of MSA subgroups.

The broader impact is clear: as viral science coverage increasingly highlights biomarkers, this work positions EEG as a feasible, noninvasive tool for capturing disease-linked brain network remodeling. For families facing MSA, the research adds momentum to the quest for earlier diagnosis and more targeted interventions.